Corifollitropin Alfa and Embryo Morphokinetics

CompletedOBSERVATIONAL
Enrollment

1,351

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2018

Conditions
Infertility
Interventions
DRUG

ELONVA

Elonva is a solution for injection that contains the active substance corifollitropin alfa. It is available as a pre-filled syringe (100 and 150 micrograms).Elonva is used in women who are undergoing fertility treatment to stimulate the development of more than one mature egg at a time in the ovaries.

DRUG

PUREGON

Puregon contains the active substance follitropin beta. fertilisation). Puregon is administered to stimulate the ovaries to produce more than one egg at a time

Trial Locations (1)

8143

Das Kinderwunsch Institut Schenk GmbH, Dobl

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Kinderwunsch Institut GmbH

OTHER

NCT04142190 - Corifollitropin Alfa and Embryo Morphokinetics | Biotech Hunter | Biotech Hunter